INGLOBE SOLUTIONS LTD.

INGLOBE SOLUTIONS LTD.

Welcome to Inglobe Solutions, your partner for your regulatory affairs management services and projects.

Inglobe Solutions Ltd. is a regulatory affairs management consulting firm located in Ottawa, the national capital of Canada.

We have over 17 years of experience in GMP and licensing requirements under the FDA and CDSA and related regulations. As a former Health Canada officer, we know the licensing process and submission procedures.

We offer comprehensive regulatory affairs management services: We help Canadian establishments operating in the pharmaceuticals, medical devices, natural health products, food and cosmetics industries meet Health Canada regulatory and licensing requirements.

We plan, prepare and file licensing submissions on behalf of our clients and provide support throughout the process.

Our regulatory affairs management consulting services focus on the following:

Regulatory Strategy
Management Sonsulting, Support and Leadership
Government Affairs
Quality Assurance

Our consulting services cover the following health products categories:

Innovative drugs
Generic drugs
Biologics/biotechnology
Active pharmaceutical ingredients
Cosmetics
Medical devices
Natural health products
OTC/non-prescription drugs
Veterinary
Food supplement products

Feel free to contact us for further information.

Related

Focal Point Research Inc.

Focal Point Research Inc.

Focal Point Research is a unique consulting company, which has the ability to assist with regulatory approvals, label & ingredient compliance, quality assurance and beyond....

December 20, 2024

Allucent

Allucent

Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We...

October 15, 2024

Lezayre e-Submissions Ltd.

Lezayre e-Submissions Ltd.

• Lezayre e-Submissions Ltd. was founded in 2015 and is located on the West Coast of Canada • We provide support for document formatting (Modules 1 – 5) and Regulatory eCTD...

September 11, 2024